Results 81 to 90 of about 4,412 (151)

Humoral Immune Response to Breakthrough Infection With SARS‐CoV‐2 Delta and Omicron Variants

iLABMED, Volume 3, Issue 3, Page 266-274, September 2025.
Patients with breakthrough infections of the Omicron variant exhibited significantly higher levels of neutralizing antibodies and IgG than those infected with the Delta variant. By contrast, Delta‐infected patients showed higher levels of IgM and IgA than Omicron‐infected patients.
Xihong Zhang, Chungen Qian, Huixia Gao, Li Yang, Yuling Wang, Ying Huang, Xin Zhang, Aidong Feng, Calvin Q. Pan, Yuzhu Shi, Ying Chen, Bangning Cheng, Erhei Dai   +12 more
wiley   +1 more source

COVID-19 Vaccine Boosters: Rationale, Efficacy, and Implementation Strategies [PDF]

, 2023
The development of COVID-19 vaccines has been a major milestone in controlling the pandemic. However, with the emergence of SARS-CoV-2 variants and the potential for waning immunity, vaccine booster doses have become an essential consideration for ...
Bilegtsaikhan Tsolmon
core   +2 more sources

COVID‐19 Vaccine Hesitancy, Self‐Reported Adverse Events, and Determinants Among Ethiopian Healthcare Professionals During COVID‐19 Pandemic

Public Health Challenges, Volume 4, Issue 3, September 2025.
Among Ethiopian HCPs, 45.6% hesitated to take the first COVID‐19 vaccine dose due to safety and efficacy concerns. Addressing these through transparent communication and religious engagement is crucial to boost vaccine uptake. ABSTRACT This nationwide cross‐sectional online survey aimed to assess coronavirus disease 2019 (COVID‐19) vaccine hesitancy ...
Alfoalem Araba Abiye, Sisay Endale, Zenebe Negash, Shemsu Umer Hussen, Dawit Teshome Gebregeorgise, Melaku Tileku Tamiru, Dessale Abate Beyene, Hana Shafi Amde, Amanuel Yishak Negash   +8 more
wiley   +1 more source

Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 Infection

Vaccines, 2022
Information on the effects of a heterologous booster in adult patients first vaccinated with the BBIBP-CorV vaccine is limited. This prospective cohort study evaluated the humoral response of 152 healthcare workers (HCWs) from a private laboratory in ...
Miguel Hueda-Zavaleta, Juan C. Gómez de la Torre, José Alonso Cáceres-Del Aguila, Cecilia Muro-Rojo, Nathalia De La Cruz-Escurra, Daniella Arenas Siles, Diana Minchón-Vizconde, Cesar Copaja-Corzo, Fabrizzio Bardales-Silva, Vicente A. Benites-Zapata, Alfonso J. Rodriguez-Morales   +10 more
doaj   +1 more source

COVID-19 Vaccines: Development, Efficacy, Safety, and Global Distribution [PDF]

, 2023
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has had a profound impact on global public health, healthcare systems, and economies.
Bilegtsaikhan Tsolmon
core   +2 more sources

Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application

Journal of Medical Virology, Volume 97, Issue 6, June 2025.
ABSTRACT Adeno‐associated virus (AAV) is a non‐enveloped DNA virus infecting a wide variety of species, tissues, and cell types, which is recognized as a safe and effective method for delivering therapeutic transgenes. AAV vector is the most popular viral gene delivery system in clinical delivery systems with unique and multiple advantages, such as ...
Ling Yin, Hongliang He, Hongliang Zhang, Yuhua Shang, Chengbo Fu, Songquan Wu, Tengchuan Jin   +6 more
wiley   +1 more source

The relationship between vaccination and uveitis: A comprehensive review of immune response, risk assessment, and clinical implications

Eye &ENT Research, Volume 2, Issue 1, Page 5-17, March 2025.
The review illustrates the possible immune responses provoked by diverse vaccines, encompassing the hepatitis B virus vaccine, human papillomavirus vaccine, measles‐mumps‐rubella combined vaccine, COVID‐19 vaccine and hepatitis A vaccine. These reponses span activation of the immune system, hypersensitivity reactions, molecular mimicry, and the role of
Yihan Zhang, Tianyu Tao, Zhaohuai Li, He Li, Qi Jiang, Lei Zhu, Wenru Su   +6 more
wiley   +1 more source

Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older

Expert Review of Vaccines, 2023
Background Because SARS-CoV-2 mutations and immunity wane over time, a third dose of heterologous COVID-19 vaccine is proposed for individuals primed with inactivated COVID-19 vaccine.
Yingping Chen, Xinpei Zhang, Lihui Gong, Zhenzhen Liang, Xiaosong Hu, Bo Xing, Yuting Liao, Lingfeng Yuan, Gang Chen, Huakun Lv   +9 more
doaj   +1 more source

Self‐Reported Adverse Events Following COVID‐19 Vaccination Among Medical Sciences Students After a Symptomatology Training Program: A Cross‐Sectional Study

Health Science Reports, Volume 8, Issue 3, March 2025.
ABSTRACT Background and Aims Accurate and transparent investigation of adverse events (AEs) following COVID‐19 vaccination enhances social trust and confidence in vaccination programs. This study aimed to assess the prevalence of COVID‐19 vaccination‐related AEs among medical sciences students. Methods In this cross‐sectional study, a self‐administered
Taraneh Tavanaei Tamanaei, Mohammad Bagher Oghazian, Mehran Mojtabaee, Mojdeh Faregh, Sahar Oghazian, Erfan Tavana, Amin Hoseinzadeh, Ramin Haghighi   +7 more
wiley   +1 more source

Factores de riesgo para la presencia de Eventos Supuestamente Atribuidos a la Vacunación o Inmunización (ESAVI) en la vacunación con BBIBP-CorV contra COVID-19 en Trabajadores de EsSalud en La Libertad en 2021 [PDF]

, 2023
La vacuna BBIBP-CorV fue la primera vacuna para COVID-19 que llegó al Perú, sin embargo, generó muchas dudas en la población sobre su seguridad por su aprobación antes de cumplir con todas las fases correspondientes.
Solar Camacho, Marco Antonio Luis, Solar Camacho, Marco Antonio Luis   +1 more
core